We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.


Mac-1:GP1b alpha and Immune Activation: Novel Mechanisms of Cardiovascular Events in Systemic Lupus Erythematosus (MACTIVATION-SLE)

blood cells
AGE: 18 - 99 years old
TYPE: Experimental Intervention Study
CONDITION: Systemic Lupus Erythematosus
LOCATIONS: UH Cleveland Medical Center

Learn more about this research study

Please contact the study coordinator, Luke Molitor, at 216-844-7223 for more information or complete the online form below.

Purpose of Study

The purpose of this study is to understand the impact of your immune system on blood platelets, which are cells that circulate in the bloodstream and help form blood clots. Blood clots are important if you are bleeding, but when platelets are incorrectly activated, strokes and heart attacks can occur. This study will use blood samples to determine whether platelets are activated at the same time as SLE disease activity.

Who Can Participate?

Participants between 18 years and older who have been diagnosed with systemic lupus erythematosis may be eligible for this study.

Participants without an auto immune disorder are also needed for this study. These participants will have one visit which will include a blood test and survey related to their health.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot

  • StudyID# 20210597